NCT03429738View on ClinicalTrials.gov

Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 27, 2014

Primary Completion Date

May 5, 2014

Study Completion Date

May 5, 2014

Conditions
Pain, HeadPain, AcutePain, BackFever
Interventions
DRUG

Ibuprofen/Pseudoephedrine HCl 200/30 mg Film-Coated Tablets

Experimental drug

DRUG

RhinAdvil Rhume 200 mg/30 mg Film-Coated Tablets

Active Comparator

Trial Locations (1)

MIS 3V6

Pharma Medica Research Inc., Toronto

Sponsors
All Listed Sponsors
collaborator

Pharma Medica Research, Inc.

INDUSTRY

lead

Institut für Pharmakologie und Präventive Medizin

NETWORK

NCT03429738 - Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets | Biotech Hunter | Biotech Hunter